Jane Sui

Advanced Medical Oncology Fellow at Memorial Sloan Kettering Cancer Center. Interested in thoracic oncology. From Malaysia to Ireland and now in New York

[Jarushka Naidoo @DrJNaidoo]

#ASCO23

Super proud of our Irish ☘️ poster presenters ⁦@ASCO⁩ this year, a snapshot of their work👇 in breast, lung, GU & sarcoma

And also..girl power 🔥
⁦@RCPI_news⁩ ⁦⁦@CancerInstIRE⁩ ⁦@CanResUCC⁩ ⁦@CancerCentreIre⁩ ⁦@WomenMedIreland⁩

[Journal of Clinical Oncology @JCO_ASCO]

Lead author @RielyMD of @MSKCancerCenter: "Overall, this shows efficacy for both first-line and second-line use of encorafenib and binimetinib for patients with BRAFV600E-mutant metastatic NSCLC."

Read the paper: https://t.co/xR4UeGZhzz #ASCO23 #lcsm

[Eric K. Singhi, MD @lungoncdoc]

🚨You’re going to want to BOOKMARK this one #OncTwitter #LCSM @OncoAlert

👇🏽 Depicts why:
1️⃣ NGS in early-stage dz is becoming more relevant
2️⃣ Shared decision-making matters
3️⃣ Personalized medicine is important

#ASCO23 @JuliaRotow @jillfeldman4 @DeepaRangachari @delvysra

[Conquer Cancer, the ASCO Foundation @ConquerCancerFd]

Congratulations to all of tonight's honorees! You are a special group of dedicated #cancerresearchers. #WeConquerCancer #ASCO23